Can Phoslock Environmental Technologies Limited (ASX:PET) Improve Its Returns?

    Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is for those who would like to learn about Return On Equity (ROE). By way of learning-by-doing, we'll look at ROE to gain a better understanding of Phoslock Environmental Technologies Limited (ASX:PET).

    Phoslock Environmental Technologies has a ROE of 1.4%, based on the last twelve months. One way to conceptualize this, is that for each A$1 of shareholders' equity it has, the company made A$0.014 in profit.

    View our latest analysis for Phoslock Environmental Technologies

    Advertisement

    How Do You Calculate Return On Equity?

    The formula for return on equity is:

    Return on Equity = Net Profit ÷ Shareholders' Equity

    Or for Phoslock Environmental Technologies:

    1.4% = AU$338k ÷ AU$24m (Based on the trailing twelve months to June 2019.)

    Most know that net profit is the total earnings after all expenses, but the concept of shareholders' equity is a little more complicated. It is the capital paid in by shareholders, plus any retained earnings. You can calculate shareholders' equity by subtracting the company's total liabilities from its total assets.

    What Does Return On Equity Signify?

    ROE measures a company's profitability against the profit it retains, and any outside investments. The 'return' is the yearly profit. A higher profit will lead to a higher ROE. So, all else being equal, a high ROE is better than a low one. Clearly, then, one can use ROE to compare different companies.

    Does Phoslock Environmental Technologies Have A Good ROE?

    Arguably the easiest way to assess company's ROE is to compare it with the average in its industry. The limitation of this approach is that some companies are quite different from others, even within the same industry classification. If you look at the image below, you can see Phoslock Environmental Technologies has a lower ROE than the average (12%) in the Commercial Services industry classification.

    ASX:PET Past Revenue and Net Income, August 25th 2019
    ASX:PET Past Revenue and Net Income, August 25th 2019

    That's not what we like to see. We prefer it when the ROE of a company is above the industry average, but it's not the be-all and end-all if it is lower. Nonetheless, it might be wise to check if insiders have been selling.

    The Importance Of Debt To Return On Equity

    Companies usually need to invest money to grow their profits. That cash can come from retained earnings, issuing new shares (equity), or debt. In the first two cases, the ROE will capture this use of capital to grow. In the latter case, the use of debt will improve the returns, but will not change the equity. Thus the use of debt can improve ROE, albeit along with extra risk in the case of stormy weather, metaphorically speaking.

    Phoslock Environmental Technologies's Debt And Its 1.4% ROE

    The Key Takeaway

    Return on equity is one way we can compare the business quality of different companies. Companies that can achieve high returns on equity without too much debt are generally of good quality. All else being equal, a higher ROE is better.

    Having said that, while ROE is a useful indicator of business quality, you'll have to look at a whole range of factors to determine the right price to buy a stock. The rate at which profits are likely to grow, relative to the expectations of profit growth reflected in the current price, must be considered, too. So I think it may be worth checking this free this detailed graph of past earnings, revenue and cash flow .

    If you would prefer check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

    We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

    If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.

    Advertisement

    Weekly Picks

    LO
    Lou_Basenese
    CUE logo
    Lou_Basenese on Cue Biopharma ·

    Cue Biopharma (NASDAQ: CUE): The Scientist Behind Xolair Just Gave Cue a Next-Generation Shot at the Same Multi-Billion-Dollar Market

    Fair Value:US$7056.5% undervalued
    22 users have followed this narrative
    0 users have commented on this narrative
    5 users have liked this narrative
    HA
    HarishPK
    ADBE logo
    HarishPK on Adobe ·

    Adobe: A Probabilistic Case for Undervaluation

    Fair Value:US$317.225.0% undervalued
    9 users have followed this narrative
    4 users have commented on this narrative
    6 users have liked this narrative
    NI
    niteco
    AVGO logo
    niteco on Broadcom ·

    A Capital Allocation Favorite with Structural Importance

    Fair Value:US$651.0539.8% undervalued
    4 users have followed this narrative
    0 users have commented on this narrative
    0 users have liked this narrative
    TO
    Tokyo
    OKTA logo
    Tokyo on Okta ·

    Good foundation, but now it's all about the next steps

    Fair Value:US$15120.6% undervalued
    82 users have followed this narrative
    7 users have commented on this narrative
    11 users have liked this narrative

    Updated Narratives

    VA
    Valtersa
    4018 logo
    Valtersa on Almoosa Health ·

    The profit margin of Almoosa Health is set to climb 13.38%

    Fair Value:ر.س130.949.0% undervalued
    1 users have followed this narrative
    0 users have commented on this narrative
    0 users have liked this narrative
    QU
    QuanD
    TEM logo
    QuanD on Tempus AI ·

    An Overlooked AI Play That’s Quietly Building a Healthcare Data Empire

    Fair Value:US$65.925.9% undervalued
    1 users have followed this narrative
    0 users have commented on this narrative
    0 users have liked this narrative
    TH
    543931 logo
    thepacific on Veefin Solutions ·

    Undervalued, Underestimated

    Fair Value:₹469.1533.1% undervalued
    11 users have followed this narrative
    1 users have commented on this narrative
    0 users have liked this narrative

    Popular Narratives

    MA
    martinarauz
    NU logo
    martinarauz on Nu Holdings ·

    Investment Analysis (May 2026)

    Fair Value:US$22.7447.8% undervalued
    58 users have followed this narrative
    0 users have commented on this narrative
    15 users have liked this narrative
    CL
    Clive_Thompson
    TTWO logo
    Clive_Thompson on Take-Two Interactive Software ·

    Take-Two Interactive: The Calm Before the Storm NASDAQ: TTWO Last Price: $242.41 Date: May 15, 2026

    Fair Value:US$276.9723.4% undervalued
    57 users have followed this narrative
    0 users have commented on this narrative
    14 users have liked this narrative
    NI
    niteco
    HON logo
    niteco on Honeywell International ·

    Honeywell - The Demand-Side of the AI Infrastructure

    Fair Value:US$320.1932.6% undervalued
    48 users have followed this narrative
    0 users have commented on this narrative
    19 users have liked this narrative